anmelden
OMX Stockholm PI
1.073,80
PKT
-11,59
PKT
-1,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 20.05.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 18.05.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 12.05.20 | Hennes Mauritz (H M, H&M) Equal-Weight | Morgan Stanley | |
| 11.05.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 07.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 05.05.20 | Nokia buy | Deutsche Bank AG | |
| 04.05.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.05.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 01.05.20 | Nokia Equal weight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | Nokia Neutral | Credit Suisse Group | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 30.04.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | Nokia buy | UBS AG | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 30.04.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 30.04.20 | AstraZeneca Reduce | HSBC | |
| 29.04.20 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 29.04.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 28.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 28.04.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 28.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Nokia Neutral | Credit Suisse Group | |
| 27.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Volvo (B) Neutral | UBS AG |